期刊文献+

高糖环境下肝细胞生长因子对血管内皮细胞增殖及c-met mRNA表达作用的研究 被引量:2

下载PDF
导出
摘要 糖尿病患者中动脉粥样硬化性疾病的患病率高、发病年龄轻、病情进展快、多脏器同时受累较多。糖尿病以慢性高血糖为主要共同特征。高血糖致血管内皮细胞受损是形成动脉粥样硬化的重要原因之一,因而保护血管内皮细胞可抑制动脉粥样硬化,减少糖尿病患者心血管病患病率。肝细胞生长因子(HGF)是由间质来源细胞分泌的多效性生长因子,具有促进多种类型的细胞增殖、迁移和新生血管形成的作用。HGF通过与c—met结合而发挥其生物学作用,HGF对血管内皮细胞的促有丝分裂作用在各种血管生长因子中是最强的。
出处 《中国药物与临床》 CAS 2010年第2期169-171,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献10

  • 1Morishita R, Aoki M, Hashiya N, et al. Therapeutic angiogenesis using hepatocyte growth factor (HGF). J Curr Gene Ther, 2004,4 (2):199-206.
  • 2Veronique N,Saadla F,Josee G,et al. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cell:ecidence for a role of hepatocyte growth factor. Hepatology, 1997,26 (6):1458-1466.
  • 3Yoshida S, Harada T,Mitsunafi M,et al. Hepatocyte growth factot/Met System promotes endometrial and endometriotic stromal cell invasion via autoerine and paracrine pathways. Clin Endocrinol Metab, 2004,89(2):823-832.
  • 4Tschoepe D,Roesen P,Schwippert B,et al. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost, 1993,19(2):122-128.
  • 5Nakagami H,Morishita R,Yamamoto K,et al. Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane. Diabetes, 2002,51(8): 2604-2611.
  • 6Morishita R,Nakamura S,Nakamura Y,et al. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes mellitus. Diabetes, 1997,46 ( 1 ): 138-142.
  • 7Nakagami H,Morishita R,Yamamoto K,et al. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and akt in endothelial cells. Hypertension,2001,37 (2): 581-586.
  • 8Rahman S, Patel Y, Murray J, et al. Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells. BMC Cell Biol, 2005,6 ( 1 ) :8.
  • 9Morishita R, Aoki M, Hashiya N, et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Circulation,2004,44(2):203-209.
  • 10Reddy V,Huh C G,Thorgeirsson S,et al. Intact signaling via the hepatocyte growth factor (HGF) receptor, c-Met, is required for normal glucose tolerance and beta cell function: conditional knock out of c-Met in the beta cell. J Diabetes,2003,52(Suppl 1): 384.

同被引文献8

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部